C9orf72 and amyotrophic lateral sclerosis: This case-control study examines the use of fluorine 18–labeled fluorodeoxyglucose positron emission tomographic imaging to detect glucose metabolic changes in individuals who are presymptomatic carriers of a mutation in the C9orf72 gene that leads to amyotrophic lateral sclerosis and frontotemporal dementia.